NIPH Clinical Trials Search


Clinical TrialsSearch results


Number of results: 55214
  • Recruitment status
  • Title of the study
  • Health Condition
  • Primary sponsor
  • Date of registration
  • Recruiting

  • Allogeneic HSCT with Fludarabin plus TBI conditioning regimen for elderly patients with hematological malignancies: A phase I/II study
  • 1. Acute lymphoblastic leukemia with or without Philadelphia chromosome: any CR or non-CR with marrow blasts <50%. 2. Acute myeloid leukemia: any CR or non-CR with marrow blasts <50%. 3. Myelodysplastic syndrome: IPSS intermediate-II or high. Relapse after remission. 4. Malignant lymphoma 1) Indolent lymphoma (including Mantle cell lymphoma): Chemo refractory case 2) Aggressive lymphoma: PR1, >CR1, or good PR. 3) Highly aggressive lymphoma: any CR or good PR.
  • Saitama Medical Center,Jichi Medical University
  • 2010-09-01

Progress situation

The subject of age and gender